Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP669721.RAJi2TRCK3hQWtx8XYVJFMgK5FVTdjWG-tEoTU5g0156g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP669721.RAJi2TRCK3hQWtx8XYVJFMgK5FVTdjWG-tEoTU5g0156g130_assertion type Assertion NP669721.RAJi2TRCK3hQWtx8XYVJFMgK5FVTdjWG-tEoTU5g0156g130_head.
- NP669721.RAJi2TRCK3hQWtx8XYVJFMgK5FVTdjWG-tEoTU5g0156g130_assertion description "[Angiotensinogen was selected because of the putative link between it and mild to moderate essential hypertension and nephrosclerosis; angiotensin-converting enzyme because of its possible contribution to diabetic nephropathy; and renin, the angiotensin II receptor, and kallikrein because of their roles in hypertension and renal perfusion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP669721.RAJi2TRCK3hQWtx8XYVJFMgK5FVTdjWG-tEoTU5g0156g130_provenance.
- NP669721.RAJi2TRCK3hQWtx8XYVJFMgK5FVTdjWG-tEoTU5g0156g130_assertion evidence source_evidence_literature NP669721.RAJi2TRCK3hQWtx8XYVJFMgK5FVTdjWG-tEoTU5g0156g130_provenance.
- NP669721.RAJi2TRCK3hQWtx8XYVJFMgK5FVTdjWG-tEoTU5g0156g130_assertion SIO_000772 8989734 NP669721.RAJi2TRCK3hQWtx8XYVJFMgK5FVTdjWG-tEoTU5g0156g130_provenance.
- NP669721.RAJi2TRCK3hQWtx8XYVJFMgK5FVTdjWG-tEoTU5g0156g130_assertion wasDerivedFrom befree-20150227 NP669721.RAJi2TRCK3hQWtx8XYVJFMgK5FVTdjWG-tEoTU5g0156g130_provenance.
- NP669721.RAJi2TRCK3hQWtx8XYVJFMgK5FVTdjWG-tEoTU5g0156g130_assertion wasGeneratedBy ECO_0000203 NP669721.RAJi2TRCK3hQWtx8XYVJFMgK5FVTdjWG-tEoTU5g0156g130_provenance.